{"filing":{"accession_number":"0001437749-26-026573","cik":"0000875657","ticker":"ULBI","company_name":"ULTRALIFE CORP","form":"8-K","filing_date":"2026-08-07","report_date":"2026-08-07","primary_document":"ulbi20260807_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/875657/000143774926026573/ulbi20260807_8k.htm"},"events":[{"id":26191,"run_id":23788,"accession_number":"0001437749-26-026573","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a straightforward earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states \"Ultralife Corporation issued a press release regarding the financial results for its second quarter ended June 30, 2026,\" with the full press release attached as Exhibit 99.1. The release reports key financial metrics including revenue ($47.9M), gross profit ($13.9M), operating income ($3.4M), net income ($2.5M), and EPS ($0.15), along with segment performance and forward guidance. This is a material quarterly earnings disclosure typical of Item 2.02 filings.","company_name":"ULTRALIFE CORP","ticker":"ULBI","filing_date":"2026-08-07","form":"8-K","submitted_at":null,"items":[{"id":27222,"accession_number":"0001437749-26-026573","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a straightforward earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states \"Ultralife Corporation issued a press release regarding the financial results for its second quarter ended June 30, 2026,\" with the full press release attached as Exhibit 99.1. The release reports key financial metrics including revenue ($47.9M), gross profit ($13.9M), operating income ($3.4M), net income ($2.5M), and EPS ($0.15), along with segment performance and forward guidance. This is a material quarterly earnings disclosure typical of Item 2.02 filings.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T02:15:34.382131+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27222,"accession_number":"0001437749-26-026573","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a straightforward earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states \"Ultralife Corporation issued a press release regarding the financial results for its second quarter ended June 30, 2026,\" with the full press release attached as Exhibit 99.1. The release reports key financial metrics including revenue ($47.9M), gross profit ($13.9M), operating income ($3.4M), net income ($2.5M), and EPS ($0.15), along with segment performance and forward guidance. This is a material quarterly earnings disclosure typical of Item 2.02 filings.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T02:15:34.382131+00:00","company_name":"ULTRALIFE CORP","ticker":"ULBI","filing_date":"2026-08-07"}]}